Interactions between platelets and leukocytes during hemodialysis

Artificial Organs

Volumn 23, Issue 1, 1999, Pages 23-28

  Bonomini, Mario ^a,b   Sirolli, Vittorio ^a   Stuard, Stefano ^a   Settefrati, Nicola ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

Biocompatibility; Hemodialysis membrane; Leukocytes; Platelet leukocyte interactions; Platelets; Reactive oxygen species

Indexed keywords

DIALYSIS; HEMODIALYZERS; OXYGEN; PLATELETS;

CELL/B.E; CONDITION; HAEMODIALYSIS; HAEMODIALYSIS MEMBRANES; LEUCOCYTES; MICROAGGREGATES; PLATELET- LEUCOCYTE INTERACTION; REACTIVE OXYGEN SPECIES; RECIPROCAL ACTIVATION;

BIOCOMPATIBILITY;

BETA 2 MICROGLOBULIN; CATHEPSIN D; CD15 ANTIGEN; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR;

AMYLOIDOSIS; ARTHROPATHY; ATHEROSCLEROSIS; BIOCOMPATIBILITY; CELL AGGREGATION; CELL INTERACTION; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMOSTASIS; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

EID: 0032907913     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1999.06271.x     Document Type: Review

References (52)

1. Bonomini V. Introducing the biology of bioincompatibility in dialysis. Nephrol Dial Transplant 1991;6(Suppl. 2):1-3.
2. Craddock PR, Ferh J, Brigham KL, Kronenberg RS, Jacobs HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-74.
3. Pereira BJG, Dinarello CA. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994;9(Suppl. 2):60-71.
4. Schulman G, Arias R, Diehl S, Silverberg M, Arbeit LA. A comparison of the ability of dialysis membranes to activate Hageman factor (Abstract). Kidney Int 1986;29:224.
5. Mahiout A, Jorres A, Meinhold H, Kessel M. Prostaglandin production and extracorporeal complement activation by dialyzer membranes. Trans Am Soc Artif Intern Organs 1986;32:88-92.
6. Mahiout A, Jorres A, Schultze G, Meinhold H, Kessel M. Eicosanoid release as laboratory indicator of biocompatibility. Artif Organs 1989;13:251-4.
7. Schmidt B, Mujais SK. Evaluation of dialysis membrane-blood compatibility: Experimental methods. Contrib Nephrol 1995;113:32-44.
8. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-94.
9. Hakin RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 1984;26:194-200.
10. Craddock PR, Hammersmith DE, White JG, Dalmasso AP, Jacob HS. Complement (C5a) induced granulocyte aggregation in vitro: A possible mechanism of complement mediated leukostasis and leukopenia. J Clin Invest 1977;60:260-4.
11. Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int 1994;46:489-95.
12. Faint RW. Platelet-neutrophil interactions: Their significance. Blood Ret 1992;6:83-91.
13. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-9.
14. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte platelet adhesion in whole blood. Blood 1991;78:1730-7.
15. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
16. Bazzoni G, Dejana E, Del Maschio A. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991;76:491-9.
17. Stenberg PE, McEver RP, Shuman MA, Jaques YV, Bainton DF. A platelet alpha granule membrane protein (GMP140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880-5.
18. Larsen E, Celia A, Gilbert GE, Furie BA, Erban JK, Bonfanti R, Wagner DD, Furie BC. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-12.
19. Stuard S, Carreno M-P, Poignet J-L, Albertazzi A, Haeffner-Cavaillon N. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int 1995;48:93-102.
20. Moore KL, Varki A, McEver RP. GMP-140 binds to a glycoprotein receptor on human neutrophils: Evidence for a lectin-like interaction. J Cell Biol 1991;112:491-9.
21. Bonomini M, Stuard S, Settefrati N, Santarelli P, Tetta C, Albertazzi A. A synthetically modified cellulose (SMC) membrane for haemodialysis (HD): Biocompatibility and functional characterization (Abstract). Nephrol Dial Transplant 1996;11:A233.
22. Tetta C, Bonomini M, Stuard S, Wratten ML, Tropea F, Haeffner-Cavaillon N, Careno MP, Alberatazzi A. Oxygen radical production during haemodialysis (HD) (Abstract). Nephrol Dial Transplant 1997;12:A173.
23. Carreno MP, Stuard S, Bonomini M, Settefrati N, Tetta C, Albertazzi A, Haeffner-Cavaillon N. Soluble and cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol Dial Transplant 1996;11:2248-57.
24. Stuard S, Bonomini M, Settefrati N, Albertazzi A. Platelet-neutrophil interactions during hemodialysis: A proposed biocompatibility approach. Int J Artif Organs 1998;21:75-82.
25. Bonomini M, Stuard S, Albertazzi A. Cell-associated adhesion molecules in hemodialysis. Int J Immunopathol Pharmacol 1997;10:37-44.
26. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993;70:514-21.
27. Ware JA, Heistad DD. Platelet endothelium interactions. N Engl J Med 1993;328:628-35.
28. Evangelista V, Piccardoni P, White JG, de Gaetano G, Cerletti C. Cathepsin-G dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: Role of P-selectin-mediated cell-cell adhesion. Blood 1993;81:2947-57.
29. Brady HR, Papayianni A, Serhan CN. Leukocyte adhesion promotes biosynthesis of lipoxygenase products by transcellular routes. Kidney Int 1994;45(Suppl. 45):S90-7.
30. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin. J Immunol 1993;151:3267-73.
31. Dallegri F, Ballestrero A, Ottonello L, Patrone F. Platelets as scavengers of neutrophil-derived oxidants: A possible defence mechanism at sites of vascular injury. Thromb Haemost 1989;61:415-8.
32. Moon DG, van der Zee H, Weston LK, Gudewicz PW, Fenton JW II, Kaplan JE. Platelet modulation of neutrophil superoxide anion production. Thromb Haemost 1990;63:91-6.
33. Dallegri F, Ballestrero A, Ottonello L, Patrone F. Platelets as inhibitory cells in neutrophil-mediated cytolysis. J Lab Clin Med 1989;114:502-9.
34. Carulli G, Barsotti G, Cupisti A, Minnucci S, Gianfaldoni ML, Agostini B, Ambrogi F. Platelet-neutrophil interactions in uremic patients: Effects on neutrophil superoxide anion production and chemiluminescence. Nephron 1995;69:248-52.
35. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Ann Rev Physiol 1986;48:721-31.
36. Henson PM, Johnston RB. Tissue injury in inflammation: Oxidants, proteinases and cationic proteins. J Clin Invest 1987;79:669-74.
37. Himmelfarb J, Hakim RM, Holbrook DG, Leeber DA, Ault KA. Detection of granulocyte reactive oxygen species production in whole blood using flow cytometry. Cytometry 1992;13:83-9.
38. Bonomini M, Stuard S, Carreno MP, Settefrati N, Santarelli P, Haeffner-Cavaillon N, Albertazzi A. Neutrophil reactive oxygen spaces production during hemodialysis: Role of activated platelet adhesion to neutrophils through P-selection. Nephron 1997;75:402-11.
39. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J Am Soc Nephrol 1993;4:178-86.
40. Himmelfarb J, McGonagle E, Holbrook D, Toth C. Soluble component receptor I inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 1995;126:392-400.
41. Jacobs AA, Ward RA, Wellhausen SR, McLeish KR. Polymorphonuclear leukocyte function during hemodialysis. Relationship to complement activation. Nephron 1989;52:119-24.
42. Rosenkranz AR, Templ E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membrane. Clin Exp Immunol 1994;98:300-5.
43. Patel KD, Zimmermann GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991;112:749-59.
44. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-mediated endothelial injury in vitro. J Clin Invest 1981;68:1394-1403.
45. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimer NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981;68:714-21.
46. Ager A, Gordon JL. Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med 1984;159:592-603.
47. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
48. Yagi K. A biochemical approach to atherogenesis. Trends Biochem Sci 1986;11:18-9.
49. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med 1987;317:687-94.
50. Holliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993;23(Suppl. 1):118-26.
51. Galle J, Wanner C. Oxidative stress and vascular injury - Relevant for atherogenesis in uraemic patients? Nephrol Dial Transplant 1997;12:2480-3.
52. Cappelliere-Blandin C, Delaveau T, Descamps-Latscha B. Structural modifications of human beta 2-microglobulin treated with oxygen-derived radicals. Biochem J 1991;277:175-82.